Is having Herpes Zoster (shingles) a risk factor for recurrent Herpes Zoster (shingles)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Having Herpes Zoster (shingles) is a significant risk factor for recurrent Herpes Zoster (shingles), with a cumulative incidence of recurrence of 2.5% at 2 years and increasing to 10.3% at 10 years. According to a recent study in the US, with an average 5.6 years of follow-up, the risk of recurrence is substantial, highlighting the importance of preventive measures 1. The study found that the cumulative incidence of recurrence at 2,4,6,8, and 10 years was 2.5%, 4.8%, 6.6%, 8.0%, and 10.3%, respectively.

Key factors to consider in managing the risk of recurrence include:

  • The time frame for vaccination following an episode of HZ, which varies between countries, but a minimal 2-month interval is recommended 1
  • The use of zoster vaccine, either ZVL or RZV, which is recommended after a prior episode of HZ to reduce the risk of recurrence 1
  • The importance of early antiviral treatment, such as acyclovir, valacyclovir, or famciclovir, within 72 hours of symptom onset to reduce the severity and duration of the outbreak

Vaccination with zoster vaccine, either ZVL or RZV, after a prior episode of HZ is recommended to reduce the risk of recurrence, with a minimal 2-month interval between the episode and vaccination 1. This recommendation is based on the high rates of HZ recurrence after a prior episode, and the documented minimal interval between an episode of HZ and recurrence of 2 months.

From the Research

Herpes Zoster Recurrence

Having Herpes Zoster (shingles) can be a risk factor for recurrent Herpes Zoster (shingles). The following points highlight the relationship between the initial episode and the recurrence:

  • The incidence rate of Herpes Zoster recurrence is estimated to be around 1.7-16.6 cases per 1000 person-years in general populations 2.
  • Studies have reported that approximately 1.2-9.6% of individuals may experience Herpes Zoster recurrence after an initial episode 2.
  • Recognized risk factors for Herpes Zoster recurrence include immunocompromised status, female sex, family history, and comorbidities such as diabetes 2.
  • Other factors that may predispose individuals to recurrence include long-lasting pain after the initial Herpes Zoster episode and the presence of herpes zoster ophthalmicus 2.
  • A population-based cohort study found that the recurrence rate of Herpes Zoster is 12.0 per 1,000 person-years, with significant risk factors including old age, women, zoster-related pain longer than 30 days, concurrent hematologic malignancies, autoimmune diseases, dyslipidemia, and hypertension 3.

Risk Factors for Recurrence

The risk factors for Herpes Zoster recurrence can be categorized into several groups:

  • Demographic factors: old age, female sex 3, 2, 4.
  • Clinical factors: zoster-related pain longer than 30 days, concurrent hematologic malignancies, autoimmune diseases, dyslipidemia, and hypertension 3.
  • Comorbidities: diabetes, digestive disorders 2, 4.
  • Immunocompromised status: individuals with weakened immune systems are more likely to experience Herpes Zoster recurrence 5, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.